A Role for the Malonyl-CoA/Long-Chain Acyl-CoA Pathway of Lipid Signaling in the Regulation of Insulin Secretion in Response to Both Fuel and Nonfuel Stimuli

dc.contributor.authorRoduit, Raphaëlen
dc.contributor.authorNolan, Christopheren
dc.contributor.authorAlarcon, Cristinaen
dc.contributor.authorMoore, Patricken
dc.contributor.authorBarbeau, Annieen
dc.contributor.authorDelghingaro-Augusto, Vivianeen
dc.contributor.authorPrzybykowski, Ewaen
dc.contributor.authorMorin, Johaneen
dc.contributor.authorMassé, Frédéricen
dc.contributor.authorMassie, Bernarden
dc.contributor.authorRuderman, Neilen
dc.contributor.authorRhodes, Christopheren
dc.contributor.authorPoitout, Vincenten
dc.contributor.authorPrentki, Marcen
dc.date.accessioned2026-01-02T09:41:29Z
dc.date.available2026-01-02T09:41:29Z
dc.date.issued2004en
dc.description.abstractThe malonyl-CoA/long-chain acyl-CoA (LC-CoA) model of glucose-induced insulin secretion (GIIS) predicts that malonyl-CoA derived from glucose metabolism inhibits fatty acid oxidation, thereby increasing the availability of LC-CoA for lipid signaling to cellular processes involved in exocytosis. For directly testing the model, INSr3 cell clones overexpressing malonyl-CoA decarboxylase in the cytosol (MCDc) in a tetracycline regulatable manner were generated, and INS(832/13) and rat islets were infected with MCDc-expressing adenoviruses. MCD activity was increased more than fivefold, and the malonyl-CoA content was markedly diminished. This was associated with enhanced fat oxidation at high glucose, a suppression of the glucose-induced increase in cellular free fatty acid (FFA) content, and reduced partitioning at elevated glucose of exogenous palmitate into lipid esterification products. MCDc overexpression, in the presence of exogenous FFAs but not in their absence, reduced GIIS in all β-cell lines and in rat islets. It also markedly curtailed the stimulation of insulin secretion by other fuel and nonfuel secretagogues. In the absence of MCDc overexpression, the secretory responses to all types of secretagogues were amplified by the provision of exogenous fatty acids. In the presence of exogenous FFAs, the fatty acyl-CoA synthetase inhibitor triacsin C reduced secretion in response to glucose and nonfuel stimuli. The data show the existence of important links between the metabolic coupling factor malonyl-CoA, the partitioning of fatty acids, and the stimulation of insulin secretion to both fuel and nonfuel stimuli.en
dc.description.sponsorshipThis work was supported by grants from the Canadian Institute of Health Research (to M.P.), the Juvenile Diabetes Research Foundation (to M.P.), and the National Institutes of Health (to C.R. and V.P.). R.R. was supported by a postdoctoral fellowship from the Swiss National Science Foundation (823A-56687).en
dc.description.statusPeer-revieweden
dc.format.extent13en
dc.identifier.issn0012-1797en
dc.identifier.otherPubMed:15047616en
dc.identifier.otherORCID:/0000-0002-6964-3819/work/195663554en
dc.identifier.scopus12144291143en
dc.identifier.urihttps://hdl.handle.net/1885/733802463
dc.language.isoenen
dc.rights© 2004 The Authorsen
dc.sourceDiabetesen
dc.titleA Role for the Malonyl-CoA/Long-Chain Acyl-CoA Pathway of Lipid Signaling in the Regulation of Insulin Secretion in Response to Both Fuel and Nonfuel Stimulien
dc.typeJournal articleen
dspace.entity.typePublicationen
local.bibliographicCitation.lastpage1019en
local.bibliographicCitation.startpage1007en
local.contributor.affiliationRoduit, Raphaël; University of Montrealen
local.contributor.affiliationNolan, Christopher; University of Montrealen
local.contributor.affiliationAlarcon, Cristina; University of Washingtonen
local.contributor.affiliationMoore, Patrick; University of Washingtonen
local.contributor.affiliationBarbeau, Annie; University of Montrealen
local.contributor.affiliationDelghingaro-Augusto, Viviane; University of Montrealen
local.contributor.affiliationPrzybykowski, Ewa; University of Montrealen
local.contributor.affiliationMorin, Johane; University of Montrealen
local.contributor.affiliationMassé, Frédéric; University of Montrealen
local.contributor.affiliationMassie, Bernard; National Research Council of Canadaen
local.contributor.affiliationRuderman, Neil; Boston Universityen
local.contributor.affiliationRhodes, Christopher; University of Washingtonen
local.contributor.affiliationPoitout, Vincent; University of Washingtonen
local.contributor.affiliationPrentki, Marc; University of Montrealen
local.identifier.citationvolume53en
local.identifier.doi10.2337/diabetes.53.4.1007en
local.identifier.pure59bf81bc-4e5b-4035-830d-543adc360950en
local.identifier.urlhttps://www.scopus.com/pages/publications/12144291143en
local.type.statusPublisheden

Downloads